NAME | REB | DATE | TM | OPP | MIN | PTS | AST | STL | BLK | FGM | FGA | FG% | 3PM | 3PA | 3P% | FTM | FTA | FT% | TS% | OREB | DREB | TOV | PF | +/- | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | J. Ennis III | 10 | 8/20/2020 | ORL | @ | MIL | 25 | 8 | 2 | 1 | 0 | 3 | 9 | 33.3 | 0 | 3 | 0.0 | 2 | 2 | 100.0 | 40.5 | 4 | 6 | 1 | 4 | -4 | |
2 | J. Ennis III | 8 | 8/18/2020 | ORL | @ | MIL | 31 | 11 | 2 | 2 | 1 | 3 | 5 | 60.0 | 2 | 3 | 66.7 | 3 | 3 | 100.0 | 87.0 | 0 | 8 | 0 | 4 | +12 | |
3 | J. Ennis III | 8 | 5/9/2019 | PHI | vs | TOR | 26 | 5 | 3 | 1 | 1 | 2 | 6 | 33.3 | 0 | 2 | 0.0 | 1 | 2 | 50.0 | 36.3 | 2 | 6 | 1 | 3 | +13 | |
4 | J. Ennis III | 8 | 4/17/2017 | MEM | @ | SAS | 26 | 7 | 2 | 2 | 0 | 1 | 4 | 25.0 | 0 | 2 | 0.0 | 5 | 6 | 83.3 | 52.7 | 2 | 6 | 0 | 5 | +5 | |
5 | J. Ennis III | 6 | 8/29/2020 | ORL | @ | MIL | 30 | 9 | 1 | 0 | 0 | 4 | 11 | 36.4 | 1 | 5 | 20.0 | 0 | 0 | 40.9 | 1 | 5 | 4 | 6 | -32 | ||
6 | J. Ennis III | 6 | 4/29/2019 | PHI | @ | TOR | 24 | 13 | 2 | 0 | 1 | 4 | 10 | 40.0 | 2 | 6 | 33.3 | 3 | 5 | 60.0 | 53.3 | 1 | 5 | 0 | 2 | +7 | |
7 | J. Ennis III | 6 | 4/18/2019 | PHI | @ | BKN | 19 | 4 | 0 | 1 | 0 | 2 | 5 | 40.0 | 0 | 3 | 0.0 | 0 | 0 | 40.0 | 3 | 3 | 4 | 2 | +6 | ||
8 | J. Ennis III | 5 | 5/5/2019 | PHI | vs | TOR | 26 | 9 | 0 | 1 | 1 | 3 | 8 | 37.5 | 3 | 7 | 42.9 | 0 | 0 | 56.3 | 2 | 3 | 1 | 3 | -5 | ||
9 | J. Ennis III | 5 | 5/2/2019 | PHI | vs | TOR | 24 | 10 | 1 | 0 | 0 | 4 | 6 | 66.7 | 0 | 2 | 0.0 | 2 | 2 | 100.0 | 72.7 | 2 | 3 | 0 | 4 | +20 | |
10 | J. Ennis III | 5 | 4/22/2017 | MEM | vs | SAS | 32 | 7 | 0 | 0 | 1 | 2 | 10 | 20.0 | 0 | 3 | 0.0 | 3 | 3 | 100.0 | 30.9 | 1 | 4 | 4 | 5 | -4 | |
11 | J. Ennis III | 4 | 4/25/2017 | MEM | @ | SAS | 31 | 11 | 2 | 0 | 0 | 4 | 9 | 44.4 | 2 | 6 | 33.3 | 1 | 1 | 100.0 | 58.3 | 2 | 2 | 1 | 2 | -17 | |
12 | J. Ennis III | 3 | 8/24/2020 | ORL | vs | MIL | 23 | 6 | 1 | 2 | 1 | 2 | 8 | 25.0 | 1 | 5 | 20.0 | 1 | 2 | 50.0 | 33.8 | 1 | 2 | 1 | 3 | -11 | |
13 | J. Ennis III | 3 | 4/23/2019 | PHI | vs | BKN | 20 | 11 | 3 | 1 | 0 | 5 | 8 | 62.5 | 1 | 3 | 33.3 | 0 | 0 | 68.8 | 1 | 2 | 1 | 5 | -9 | ||
14 | J. Ennis III | 3 | 4/15/2019 | PHI | vs | BKN | 12 | 6 | 1 | 0 | 0 | 2 | 2 | 100.0 | 0 | 0 | 2 | 2 | 100.0 | 104.2 | 2 | 1 | 0 | 1 | +14 | ||
15 | J. Ennis III | 3 | 4/27/2017 | MEM | vs | SAS | 29 | 11 | 1 | 1 | 0 | 4 | 7 | 57.1 | 3 | 4 | 75.0 | 0 | 0 | 78.6 | 1 | 2 | 1 | 3 | -15 | ||
16 | J. Ennis III | 3 | 4/15/2017 | MEM | @ | SAS | 20 | 2 | 1 | 1 | 1 | 1 | 2 | 50.0 | 0 | 1 | 0.0 | 0 | 0 | 50.0 | 2 | 1 | 0 | 1 | -28 | ||
17 | J. Ennis III | 2 | 8/22/2020 | ORL | vs | MIL | 9 | 1 | 0 | 0 | 0 | 0 | 2 | 0.0 | 0 | 0 | 1 | 2 | 50.0 | 17.4 | 0 | 2 | 0 | 2 | -14 | ||
18 | J. Ennis III | 2 | 5/12/2019 | PHI | @ | TOR | 14 | 6 | 0 | 0 | 0 | 2 | 4 | 50.0 | 1 | 1 | 100.0 | 1 | 2 | 50.0 | 61.5 | 1 | 1 | 1 | 1 | -8 | |
19 | J. Ennis III | 2 | 4/20/2019 | PHI | @ | BKN | 21 | 7 | 0 | 0 | 0 | 3 | 6 | 50.0 | 1 | 3 | 33.3 | 0 | 0 | 58.3 | 1 | 1 | 1 | 5 | +3 | ||
20 | J. Ennis III | 2 | 4/20/2017 | MEM | vs | SAS | 20 | 12 | 1 | 1 | 0 | 4 | 6 | 66.7 | 1 | 3 | 33.3 | 3 | 4 | 75.0 | 77.3 | 0 | 2 | 1 | 4 | 0 | |
21 | J. Ennis III | 1 | 5/7/2019 | PHI | @ | TOR | 23 | 1 | 1 | 0 | 0 | 0 | 4 | 0.0 | 0 | 3 | 0.0 | 1 | 2 | 50.0 | 10.2 | 0 | 1 | 0 | 4 | -30 | |
22 | J. Ennis III | 1 | 4/27/2019 | PHI | @ | TOR | 21 | 11 | 1 | 0 | 0 | 4 | 5 | 80.0 | 1 | 2 | 50.0 | 2 | 4 | 50.0 | 81.4 | 1 | 0 | 1 | 1 | -18 |
ORTG
110.2
25th
DRTG
106.6
3rd
NETRTG
3.6
10th
3P%
30.8
30th